A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
Clinical trial NCT06285825 · RECRUITING
Trial details
- NCT number
- NCT06285825
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2028-08-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.